Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › COGT
SILVERARC CAPITAL MANAGEMENT, LLC position in COGT
COGENT BIOSCIENCES INC · Health Care
SILVERARC CAPITAL MANAGEMENT, LLC reported holding 1,574,698 shares of COGT (COGENT BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$50.4M, representing 6.43% of its reported portfolio and ranking #3 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed COGT holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SILVERARC CAPITAL MANAGEMENT, LLC's COGT position evolved
SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in COGT in Q3 2023 at 651,372 shares (US$6.4M). The position peaked in Q1 2026 at 1,314,189 shares, worth US$50.6M. Across 11 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,574,698 shares valued at US$50.4M — an increase of 293,991 shares quarter over quarter.. Notable position changes include a 48% increase in Q4 2023 (shares rose 14% over the following quarter), a 246% increase in Q4 2025 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 651.37K | $6.35M | New |
| Q4 2023 | 966.75K | $5.68M | Add |
| Q1 2024 | 1.04M | $6.97M | Add |
| Q2 2024 | 1.21M | $10.17M | Add |
| Q3 2024 | 1.22M | $13.19M | Add |
| Q4 2024 | 921.14K | $7.18M | Reduce |
| Q3 2025 | 360.00K | $5.17M | New |
| Q4 2025 | 1.25M | $44.23M | Add |
| Q1 2026 | 1.31M | $50.58M | Add |
| Q2 2026 | 1.28M | $49.56M | Reduce |
| Q3 2026 | 1.57M | $50.42M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About COGT and 13F data
COGT (COGENT BIOSCIENCES INC) is a Health Care company. 55 other funds we track also report a position in COGT — the largest reported positions include Fairmount Funds Management LLC (US$213.0M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$193.7M), TCG Crossover Management, LLC (US$187.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COGT
- Fairmount Funds Management LLC 5.50M sh · $212.98M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 5.01M sh · $193.74M · Q2 2026
- TCG Crossover Management, LLC 4.85M sh · $187.87M · Q2 2026
- Kynam Capital Management, LP 3.67M sh · $141.92M · Q2 2026
- Commodore Capital LP 3.05M sh · $118.03M · Q2 2026
- Octagon Capital Advisors LP 2.35M sh · $90.94M · Q2 2026
- RTW INVESTMENTS, LP 2.31M sh · $89.36M · Q2 2026
- Deep Track Capital, LP 2.00M sh · $77.40M · Q2 2026
- Venrock Adviser, LLC 1.64M sh · $63.55M · Q2 2026
- EMERALD ADVISERS, LLC 1.61M sh · $51.67M · Q3 2026
- Siren, L.L.C. 1.61M sh · $51.53M · Q3 2026
- Elmind Capital, LP 1.17M sh · $45.31M · Q2 2026
More on SILVERARC CAPITAL MANAGEMENT, LLC
FAQ
How long has SILVERARC CAPITAL MANAGEMENT, LLC held COGT?
SILVERARC CAPITAL MANAGEMENT, LLC has disclosed COGT holdings in 11 of the last 13 reported quarters, going back to Q3 2023.
What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in COGT?
As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 1.57M shares of COGT (COGENT BIOSCIENCES INC), valued at $50.42M, representing 6.43% of its reported portfolio and ranking #3.
Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling COGT?
In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC increased its position in COGT. The position peaked in Q1 2026 at 1.31M shares.
Which other funds hold COGT?
Other major institutional holders of COGT include Fairmount Funds Management LLC, DEERFIELD MANAGEMENT COMPANY, L.P., TCG Crossover Management, LLC, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.